{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T02:15:29Z","timestamp":1782008129979,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000196","name":"Fondation canadienne pour l'innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002784","name":"Canada Excellence Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jchromb.2026.124981","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T23:10:38Z","timestamp":1771801838000},"page":"124981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["LC-MS\/MS-based simultaneous high-sensitivity quantification of clinically relevant high-potency androgens and estrogens in plasma and serum"],"prefix":"10.1016","volume":"1274","author":[{"given":"Patrick","family":"Caron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Guillemette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2026.124981_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462228","article-title":"A quantitative analysis of total and free 11-oxygenated androgens and its application to human serum and plasma specimens using liquid-chromatography tandem mass spectrometry","volume":"1650","author":"Caron","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.124981_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106578","article-title":"Simultaneous measurement of 17 endogenous steroid hormones in human serum by liquid chromatography-tandem mass spectrometry without derivatization","volume":"243","author":"Gjorgoska","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchromb.2026.124981_bb0015","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jpba.2018.11.035","article-title":"Simultaneous analysis by LC-MS\/MS of 22 ketosteroids with hydroxylamine derivatization and underivatized estradiol from human plasma, serum and prostate tissue","volume":"164","author":"Hakkinen","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.124981_bb0020","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1021\/acschemneuro.3c00824","article-title":"Simultaneous determination of selected steroids with neuroactive effects in human serum by ultrahigh-performance liquid chromatography-tandem mass spectrometry","volume":"15","author":"Kaleta","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jchromb.2026.124981_bb0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jmsacl.2025.10.003","article-title":"Measurement of twenty-one serum steroid profiles by UPLC-MS\/MS for the diagnosis and monitoring of congenital adrenal hyperplasia","volume":"38","author":"Lee","year":"2025","journal-title":"J. Mass Spectrom. Adv. Clin. Lab."},{"key":"10.1016\/j.jchromb.2026.124981_bb0030","unstructured":"Y. Liu, T. Jin, Y. Wei, X. Qin, S. Deng, J. Zheng, B. Yan, Y. Nong, Y. Ye, S. Huang, Y. Long, J. Li, G. Wang, P. Huang, J. Jiang, F. Wu, Z. Mo, Y. Jiang. 2025, Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for detecting adrenocortical hormones and establishment of age-stratified reference intervals in reproductive-aged women from Guangxi, China, Ann. Lab. Med., DOI https:\/\/doi.org\/10.3343\/alm.2025.0090(2025). doi:https:\/\/doi.org\/10.3343\/alm.2025.0090."},{"key":"10.1016\/j.jchromb.2026.124981_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123941","article-title":"A comprehensive LC-MS\/MS method for the simultaneous measurement of 24 adrenal steroids: from research to clinical practice","volume":"1232","author":"Yu","year":"2024","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2026.124981_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.talo.2025.100459","article-title":"Simultaneous profiling of classic and 11-oxygenated androgens via a novel derivatization method coupled with HPLC-MS\/MS: a game-changer for endocrine disorders","volume":"11","author":"Zhang","year":"2025","journal-title":"Talanta Open"},{"key":"10.1016\/j.jchromb.2026.124981_bb0045","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jchromb.2026.124981_bb0050","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O\u2019Reilly","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jchromb.2026.124981_bb0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/JU.0000000000003049","article-title":"Preoperative circulating 11-oxygenated androgens are associated with metastasis-free survival in localized prostate cancer","volume":"209","author":"Dahmani","year":"2023","journal-title":"J. Urol."},{"key":"10.1016\/j.jchromb.2026.124981_bb0060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/JU.0000000000004333","article-title":"High 11-Ketotestosterone linked to shorter time to castration resistance in recurrent nonmetastatic prostate cancer","volume":"213","author":"Dahmani","year":"2025","journal-title":"J. Urol."},{"key":"10.1016\/j.jchromb.2026.124981_bb0065","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1186\/s12885-025-15193-7","article-title":"Androgenic effects of 11-oxyandrogens in castration-resistant prostate cancer","volume":"25","author":"Lapointe-Belleau","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jchromb.2026.124981_bb0070","article-title":"11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration","volume":"6","author":"Snaterse","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jchromb.2026.124981_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106618","article-title":"Advances and challenges in liquid chromatography-spectrometry (LC-MS) methodology for quantifying androgens and estrogens in human serum and plasma","volume":"245","author":"Wang","year":"2025","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchromb.2026.124981_bb0080","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41574-020-0336-x","article-title":"11-oxygenated androgens in health and disease","volume":"16","author":"Turcu","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jchromb.2026.124981_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105359","article-title":"Profiling steroid hormone landscape of bladder cancer reveals depletion of intratumoural androgens to castration levels: a cross-sectional study","volume":"108","author":"Kettunen","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jchromb.2026.124981_bb0090","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1210\/jc.2018-02527","article-title":"11-oxygenated C19 steroids do not decline with age in women","volume":"104","author":"Nanba","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jchromb.2026.124981_bb0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.steroids.2015.07.009","article-title":"A chromatography\/tandem mass spectrometry method for the simultaneous profiling of ten endogenous steroids, including progesterone, adrenal precursors, androgens and estrogens, using low serum volume","volume":"104","author":"Caron","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.jchromb.2026.124981_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsbmb.2017.10.021","article-title":"Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery","volume":"178","author":"Audet-Delage","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchromb.2026.124981_bb0105","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1021\/ac070494j","article-title":"Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry","volume":"79","author":"Xu","year":"2007","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.124981_bb0110","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1021\/ac050697c","article-title":"Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry","volume":"77","author":"Xu","year":"2005","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.124981_bb0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jchromb.2019.03.007","article-title":"A highly sensitive LC-MS\/MS method for the simultaneous quantitation of serum androstane-3alpha, 17beta-diol and androstane-3beta, 17beta-diol in post-menopausal women","volume":"1113","author":"Ke","year":"2019","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2026.124981_bb0120","series-title":"Bioanalytical Method Validation: Guidance for Industry","author":"Food and Drug Administration (FDA)","year":"2018"},{"key":"10.1016\/j.jchromb.2026.124981_bb0125","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1210\/clinem\/dgaa343","article-title":"Sex differences in 11-oxygenated androgen patterns across adulthood","volume":"105","author":"Davio","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jchromb.2026.124981_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2025.106717","article-title":"Artifactual elevations of 11beta-hydroxyandrostenedione and 11-ketoandrostenedione in mass spectrometry assays","volume":"250","author":"Lee","year":"2025","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchromb.2026.124981_bb0135","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1007\/s00216-022-03881-3","article-title":"Parallel targeted and non-targeted quantitative analysis of steroids in human serum and peritoneal fluid by liquid chromatography high-resolution mass spectrometry","volume":"414","author":"Andrieu","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2026.124981_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/srep32198","article-title":"Dihydrotestosterone synthesis pathways from inactive androgen 5alpha-androstane-3beta,17beta-diol in prostate cancer cells: inhibition of intratumoural 3beta-hydroxysteroid dehydrogenase activities by abiraterone","volume":"6","author":"Ando","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2026.124981_bb0145","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.steroids.2012.12.011","article-title":"What are the physiological estrogens?","volume":"78","author":"Baker","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.jchromb.2026.124981_bb0150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jsbmb.2013.01.012","article-title":"Interaction of Androst-5-ene-3beta,17beta-diol and 5alpha-androstane-3beta,17beta-diol with estrogen and androgen receptors: a combined binding and cell study","volume":"137","author":"Chen","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchromb.2026.124981_bb0155","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10549-008-0080-8","article-title":"The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance","volume":"115","author":"Sikora","year":"2009","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322600070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322600070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:19:35Z","timestamp":1777619975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157002322600070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"alternative-id":["S157002322600070X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.124981","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LC-MS\/MS-based simultaneous high-sensitivity quantification of clinically relevant high-potency androgens and estrogens in plasma and serum","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.124981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"124981"}}